Eledon Pharmaceuticals (ELDN) Shares Issued (2013 - 2014)
Eledon Pharmaceuticals (ELDN) posted Shares Issued of $2.1 million for Q4 2014, up 45.96% on a QoQ basis from $1.5 million in Q3 2014, and up 90.99% year-over-year from $1.1 million in Q4 2013.
Eledon Pharmaceuticals (ELDN) Shares Issued (2013 - 2014) Analysis & Trends
Eledon Pharmaceuticals' Shares Issued history runs 2 years deep, the most recent figure standing at $2.1 million for Q4 2014.
- Quarterly Shares Issued rose 90.99% year-over-year to $2.1 million in Q4 2014, while the trailing twelve-month figure through Dec 2014 was $2.1 million (up 90.99% YoY) and the FY2014 annual result came in at $2.1 million, up 90.99% from the prior year.
- Shares Issued was $2.1 million for Q4 2014 at Eledon Pharmaceuticals, up from $1.5 million in the prior quarter.
- Across five years, Shares Issued topped out at $2.1 million in Q4 2014 and bottomed at $1.1 million in Q4 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 154.50 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.44 Mn |
| 10 | Eledon Pharmaceuticals | 399.11 Mn | 399.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | 2.15 Mn |
| Dec 31, 2014 | 2.15 Mn |
| Sep 30, 2014 | 1.47 Mn |
| Sep 30, 2014 | 1.47 Mn |
| Dec 31, 2013 | 1.12 Mn |
| Dec 31, 2013 | 1.12 Mn |